Review

  • Ahmet Erözenci
Bull Urooncol 2005; 4: 3-4
Hematüri göz ardı edilebilir mi?
  • Ata Özen
  • Ali Barbaros Başeskioğlu
  • Cavit Can
Bull Urooncol 2011; 10: 5-8
Genetik alteration in bladder carcinoma
  • Hakan Akça
  • Onur Tokgün
Bull Urooncol 2012; 11: 10-13
New approaches to assess the morphology of renal masses
  • Barbaros Başeskioğlu
  • Cavit Can
Bull Urooncol 2011; 10: 11-15
Yüksek karbonhidratın, yağdan zengin beslenmenin ve statinlerin benign prostat hiperplazi ile ilişkisi
  • Mehmet Reşit Gören
  • Mehmet İlteriş Tekin
Bull Urooncol 2009; 8: 25-28
Testis tümörlerinde organ koruyucu cerrahi
  • Serdar Göktaş
  • Orhan Ünal Zorba
Bull Urooncol 2009; 8: 52-58
Can Bladder be Preserved with TURB + Chemotherapy instead of Radical Surgery (Can we Preserve the Bladder from Cancer)
  • Cavit Can
Bull Urooncol 2012; 11: 55-57
New treatment options for the castration resistant prostate cancer: Cabazitaxel and Spileucel-T
  • Gürbüz Görümlü
  • Erdem Göker
Bull Urooncol 2013; 12: 115-117
Bilateral testis tumors
  • Barbaros Baseskioğlu
Bull Urooncol 2012; 11: 190-192

Original Articles

Clinical Significance of Perineural Invasion in Prostate Needle Biopsy in Patients Diagnosed with Extraprostatic Extension and Seminal Vesicle Invasion after Radical Prostatectomy
  • Ozan Bozkurt
  • Serdar Çelik
  • Ömer Demir
  • Özgür Gürboğa
  • Burçin Tuna
  • Kutsal Yörükoğlu
  • Güven Aslan
Bull Urooncol 2015; 14: 5-7 DOI: 10.4274/uob.274
Transperitoneal Laparoscopic Nephrectomy-Our Initial Experiences
  • Ali Riza Türkoğlu
  • Soner Çoban
  • Muhammet Güzelsoy
  • Tuncay Özgünay
  • Murat Öztürk
  • Dursun Ünal
  • Murat Demirbaş
  • Hakan Demirci
Bull Urooncol 2016; 15: 8-12 DOI: 10.4274/uob.452
Social Awareness on Early Diagnosis and Treatment of Bladder Cancer: Importance of Age and Education
  • Doğan Değer
  • Öner Deniz Aslan
  • Kaan Çömez
  • Feyzullah Eren
  • Sedik Adırbelli
  • Güven Aslan
Bull Urooncol 2017; 16: 12-16 DOI: 10.4274/uob.767
Is Prostate Specific Antigen Density more Important than in the Diagnosis of Prostate Cancer in Patients with a Total Prostate Specific Antigen Value <10 ng/mL?
  • Soner Çoban
  • Muhammet Güzelsoy
  • Ali Rıza Türkoğlu
  • Ünal Kurtoğlu
  • Dursun Ünal
  • Noyan Can Akdur
  • Sedat Öner
  • Murat Demirbaş
Bull Urooncol 2015; 14: 83-87 DOI: 10.4274/uob.268
Role of Prostate Specific Antigen Density for the Prediction of Radical Therapy Requirement in Localized Prostate Cancer
  • Ozan Bozkurt
  • Kaan Çömez
  • Özgür Gürboğa
  • Ömer Demir
  • Güven Aslan
  • Adil Esen
Bull Urooncol 2016; 15: 103-106 DOI: 10.4274/uob.701
Immunohistochemical Study of Cyclooxygenase-2 Expression in Prostate Carcinoma: It’s Relation with Apoptosis and Angiogenesis
  • Emine Kılıç Bağır
  • Arbil Açıkalın
  • Volkan İzol
  • Gülşah Şeydaoğlu
  • Şeyda Erdoğan
Bull Urooncol 2016; 15: 144-147 DOI: 10.4274/uob.708
The Expression Frequency of Androgen Receptor, c-erbB2 and CD117 in Acinar Adenocarcinoma of Prostate and Normal Prostate Tissue and It’s Clinical Importance
  • Hülya Savaş Mutlu
  • Oğuz Aydın
  • Sancar Barış
  • Sevgi Canbaz
  • Filiz Karagöz
Bull Urooncol 2015; 14: 245-250 DOI: 10.4274/uob.376

Original Article

Evaluation of Prostatic Artery Embolization Efficiency in Benign Prostatic Hyperplasia Patients with High Comorbidity
  • İsmail Okan Yıldırım
  • Enes Duman
  • Ali Fırat
  • Hüseyin Çelik
  • Kaya Saraç
Bull Urooncol 2018; 17: 14-17 DOI: 10.4274/uob.937
The Effect of Second TURBT on Recurrence and Progression in Primary Ta High-grade Bladder Cancers: A Multicenter Clinical Trial Comparing Long-term Outcomes
  • Uygar Miçooğulları
  • Mehmet Çağlar Çakıcı
  • Burak Özçift
  • Erdem Kısa
  • Murat Keske
  • Serdar Çakmak
  • Meftun Çulpan
  • Okan Nabi Yalbuzdağ
  • Mehmet Yiğit Yalçın
  • Erkin Karaca
  • Ramazan Gökhan Atış
  • Asıf Yıldırım
Bull Urooncol 2023; 22: 20-27 DOI: 10.4274/uob.galenos.2022.2022.3.2
Obstructive Uropathy in Advanced Prostate Cancer
  • Oğuzcan Erbatu
  • Talha Müezzinoğlu
Bull Urooncol 2023; 22: 57-61 DOI: 10.4274/uob.galenos.2022.2022.10.6
Treatment of Primary Tumor in Oligometastatic Prostate Cancer: An Observational Study of the Turkish Urooncology Association Prostate Diseases Working Group
  • Murat Yavuz Koparal
  • Tevfik Sinan Sözen
  • Güven Aslan
  • Sümer Baltacı
  • Oğuzcan Erbatu
  • Levent Türkeri
  • on Behalf of the Turkish Urooncology Association
Bull Urooncol 2023; 22: 62-67 DOI: 10.4274/uob.galenos.2023.2023.1.4
Treatment Options in Low-risk Prostate Cancer Patients: A Retrospective Database Report
  • Oğuzcan Erbatu
  • Talha Müezzinoğlu
  • Bülent Akdoğan
  • Güven Aslan
  • Sinan Sözen
  • Sümer Baltacı
  • Evren Süer
  • Volkan İzol
  • Oktay Üçer
  • Süleyman Ataus
  • Levent Türkeri
  • İlker Tinay
Bull Urooncol 2023; 22: 72-75 DOI: 10.4274/uob.galenos.2022.2022.5.2
Effect of High-dose Ascorbic Acid on Prostate Cancer Cells and Angiogenesis
  • Naşide Mangır
  • Sheila MacNeil
Bull Urooncol 2020; 19: 107-111 DOI: 10.4274/uob.galenos.2020.1761
Comparison of Renal Cell Cancer Surgery During the COVID-19 Pandemic with Prepandemic Period, Turkey Multicenter Study
  • Abdullah Gürel
  • Burhan Baylan
  • Ata Özen
  • İbrahim Keleş
  • Ünal Öztekin
  • Arif Demirbaş
  • Mustafa Karalar
  • Kemal Ulusoy
  • Mehmet Yılmaz
  • Erol Erşekerci
  • Burak Elmaağaç
  • Hasan Sulhan
  • Ahmet Emin Doğan
  • Mehmet Altan
  • Murat Keske
  • Mert Ali Karadağ
Bull Urooncol 2022; 21: 119-123 DOI: 10.4274/uob.galenos.2021.2021.11.3
Role of Tissue Markers on Predicting the Prognosis of Intermediate and High-risk Non-muscle Invasive Bladder Cancer
  • Abulfaz Abbaslı
  • Sinharib Çitgez
  • Çetin Demirdağ
  • Ahmet Gürbüz
  • Ahmet Erözenci
Bull Urooncol 2020; 19: 177-181 DOI: 10.4274/uob.galenos.2020.1382
Radical Prostatectomy Outcomes in Patients with Clinical Lymph Node Involvement from The Turkish Urooncology Database
  • Hasan Hüseyin Tavukçu
  • Oğuzcan Erbatu
  • Bülent Akdoğan
  • Volkan İzol
  • Uğur Yücetaş
  • Sinan Sözen
  • Güven Aslan
  • Bahadır Şahin
  • İlker Tinay
  • Talha Müezzinoğlu
  • Sümer Baltacı
Bull Urooncol 2021; 20: 231-235 DOI: 10.4274/uob.galenos.2021.2021.5.1

Bph

How can LUTS can be treated in BPH patients with high morbidity?
  • Uğur Yücetaş
  • Gökhan Tokdaş
Bull Urooncol 2012; 11: 261-264